Sailong Pharmaceutical GroupLtd Balance Sheet Health
Financial Health criteria checks 4/6
Sailong Pharmaceutical GroupLtd has a total shareholder equity of CN¥534.1M and total debt of CN¥142.0M, which brings its debt-to-equity ratio to 26.6%. Its total assets and total liabilities are CN¥796.5M and CN¥262.4M respectively. Sailong Pharmaceutical GroupLtd's EBIT is CN¥15.9M making its interest coverage ratio 5.4. It has cash and short-term investments of CN¥32.3M.
Key information
26.6%
Debt to equity ratio
CN¥142.03m
Debt
| Interest coverage ratio | 5.4x |
| Cash | CN¥32.32m |
| Equity | CN¥534.13m |
| Total liabilities | CN¥262.35m |
| Total assets | CN¥796.48m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 002898's short term assets (CN¥242.8M) exceed its short term liabilities (CN¥218.0M).
Long Term Liabilities: 002898's short term assets (CN¥242.8M) exceed its long term liabilities (CN¥44.4M).
Debt to Equity History and Analysis
Debt Level: 002898's net debt to equity ratio (20.5%) is considered satisfactory.
Reducing Debt: 002898's debt to equity ratio has increased from 7.3% to 26.6% over the past 5 years.
Debt Coverage: 002898's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 002898's interest payments on its debt are well covered by EBIT (5.4x coverage).